Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: Brazil Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20172
20181
20202
20211
20221
20231
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Active, not recruiting5
Completed5
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
AstraZeneca2
Recepta Biopharma2
AbbVie1
Amgen1
CanariaBio Inc.1
Corcept Therapeutics1
Daiichi Sankyo1
Eli Lilly and Company1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms18
Ovarian Neoplasms16
Carcinoma, Ovarian Epithelial7
Peritoneal Neoplasms5
Recurrence2
Adrenal Gland Neoplasms1
Anus Neoplasms1
Biliary Tract Neoplasms1
Carcinoma, Adenoid Cystic1
Carcinosarcoma1

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.